PAPER Hazewinkel M, Barkhof F
SEARCH RESULTS
331254 RESULTS
PAPER Iwatsubo T
[Dementia: progress in diagnosis and treatment; editorial, towards the preclinical treatment of Alzheimer disease].
Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2089-91. PubMed: 21899138PAPER Shimohama S
[Dementia: progress in diagnosis and treatment; Topics, I. Basic knowledge of dementia and pathophysiology; 1. The concept and pathophysiology of dementia of Alzheimer-type].
Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2092-8. PubMed: 21899139PAPER Kaufmann D, Dogra AK, Wink M
Myrtenal inhibits acetylcholinesterase, a known Alzheimer target.
J Pharm Pharmacol. 2011 Oct;63(10):1368-71. PubMed: 21899553PAPER Bate C, Williams A
Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
J Biol Chem. 2011 Nov 4;286(44):37955-63. PubMed: 21900234PAPER Coker LH, Wagenknecht LE
Advanced glycation end products, diabetes, and the brain.
Neurology. 2011 Oct 4;77(14):1326-7. PubMed: 21900634PAPER Chen S, Liu AR, An FM, Yao WB, Gao XD
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4.
Age (Dordr). 2011 Sep 8; PubMed: 21901364PAPER Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wägele B, Altmaier E, , Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, Milburn MV, Prehn C, Raffler J, Ried JS, Römisch-Margl W, Samani NJ, Small KS, Wichmann HE, Zhai G, Illig T, Spector TD, Adamski J, Soranzo N, Gieger C
Human metabolic individuality in biomedical and pharmaceutical research.
Nature. 2011 Sep 1;477(7362):54-60. PubMed: 21886157PAPER McKinnon PJ
DNA repair deficiency and neurological disease.
Nat Rev Neurosci. 2009 Feb;10(2):100-12. PubMed: 19145234PAPER Borgesius NZ, de Waard MC, van der Pluijm I, Omrani A, Zondag GC, van der Horst GT, Melton DW, Hoeijmakers JH, Jaarsma D, Elgersma Y
Accelerated age-related cognitive decline and neurodegeneration, caused by deficient DNA repair.
J Neurosci. 2011 Aug 31;31(35):12543-53. PubMed: 21880916The Mega-Appeal of Nanomedicine
SERIES The European Union is banking on big returns from nanotechnology in the fight against AD. European Union Throws Megabucks at Nanomedicine EU Consortium Applies Nanotechnology to Study AD
PAPER Goldenberg MM
Some aspects in the pharmacology of diclonium bromide (2-(3,2-dichloroanilino)quinolizinium bromide). Part I: Antispasmodic action.
Arzneimittelforschung. 1976;26(3):341-6. PubMed: 9098PAPER Pokrovskiĭ AA, Tsaregorodtsev GI
[Current state and future tasks of the methodologic and idealogic operations in the scientific research institutions of the AMS of the USSR in light of the resolutions of the 25th Congress of the CPSU].
Vestn Akad Med Nauk SSSR. 1977;(4):3-23. PubMed: 868234PAPER
Hawaii's prepaid healthcare plan.
Diabetologia. 2006 Jun;49(6):1237-46. PubMed: 1657Kourosh Honarmand Ebrahimi
The Scripps Research Institute, FL campusJupiter, United States
Current Filters
No filters selected